Financial News

Financial Report: INC Research

Revenue up 13% in the quarter with backlog up 17%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research   3Q Revenues: $234.5 million (+13%) 3Q Earnings: $37.8 million (earnings were $12.6 million 3Q14) YTD Revenues: $673.4 million (+13%) YTD Earnings: $86.4 million (earnings were $26.3 million 3Q14) Comments: Revenue grew across all therapeutic areas, particularly in the central nervous system, oncology and other complex therapeutic areas. Backlog grew 17% to $1.8 billion in the quarter. Net new business awards were $327.7 million, representing a book-to-bill ratio of 1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters